In the multivariable model, we adjusted for age, race/ethnicity, tumor size, tumor grade, lymph node status, ER status, HER2 status, P53 status, and systemic therapy status (including chemotherapy and endocrine therapy). The gene discussed is TP53; the disease is neoplasm.